176 related articles for article (PubMed ID: 1689535)
1. Efficacy of moricizine in malignant ventricular arrhythmias.
Horowitz LN
Am J Cardiol; 1990 Feb; 65(8):41D-46D; discussion 68D-71D. PubMed ID: 1689535
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia.
Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME
Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588
[TBL] [Abstract][Full Text] [Related]
3. Dose effect of moricizine on suppression of ventricular arrhythmias.
Morganroth J
Am J Cardiol; 1990 Feb; 65(8):26D-31D; discussion 68D-71D. PubMed ID: 1689534
[TBL] [Abstract][Full Text] [Related]
4. Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.
Fitton A; Buckley MT
Drugs; 1990 Jul; 40(1):138-67. PubMed ID: 2202581
[TBL] [Abstract][Full Text] [Related]
5. Proarrhythmic potential of moricizine: strengths and limitations of a data base analysis.
Pratt CM
Am J Cardiol; 1990 Feb; 65(8):51D-55D; discussion 68D-71D. PubMed ID: 1689536
[TBL] [Abstract][Full Text] [Related]
6. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias.
Dorian P; Echt DS; Mead RH; Lee JT; Lebsack CS; Winkle RA
Am Heart J; 1986 Aug; 112(2):327-33. PubMed ID: 3526852
[TBL] [Abstract][Full Text] [Related]
7. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
Hession MJ; Lampert S; Podrid PJ; Lown B
Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
[TBL] [Abstract][Full Text] [Related]
8. The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardia.
Pratt CM; Francis M; Mahler S; Aogaichi K; Keus P; Young JB
Am Heart J; 1988 Oct; 116(4):897-903. PubMed ID: 2459950
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic effects of ethmozin in patients with ventricular tachycardia.
Mann DE; Luck JC; Herre JM; Magro SA; Yepsen SC; Griffin JC; Pratt CM; Wyndham CR
Am Heart J; 1984 Apr; 107(4):674-9. PubMed ID: 6367405
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and risks of moricizine in inducible sustained ventricular tachycardia.
Damle R; Levine J; Matos J; Greenberg S; Brooks R; Frumkin W; Goldberger J; Kadish AH
Ann Intern Med; 1992 Mar; 116(5):375-81. PubMed ID: 1736770
[TBL] [Abstract][Full Text] [Related]
11. [Long-term use of ethacizin in outpatients with ventricular disorders of heart rhythm].
Shugushev KhKh; Rozenshtraukh LV; Smetnev AS; Ponamarenko EL
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):16-20. PubMed ID: 2432906
[TBL] [Abstract][Full Text] [Related]
12. Ethmozine for ventricular premature complexes.
Gear K; Marcus FI; Huang SK; Fenster PE; Appleton C; Moeller V; Renaud G; Serokman R
Am J Cardiol; 1986 Apr; 57(11):947-9. PubMed ID: 2421571
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic response to moricizine in patients with sustained ventricular arrhythmias.
Powell AC; Gold MR; Brooks R; Garan H; Ruskin JN; McGovern BA
Ann Intern Med; 1992 Mar; 116(5):382-7. PubMed ID: 1736771
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation.
Miura DS; Wynn J; Torres V; Laux B; Keefe D; Somberg JC
Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of moricizine in patients with ventricular tachycardia: results of a placebo-controlled prospective long-term clinical trial.
Pratt CM; Wierman A; Seals AA; English L; Leon C; Young JB; Quinones MA; Roberts R
Circulation; 1986 Apr; 73(4):718-26. PubMed ID: 3512124
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerance of Ethmozine (moricizine HCl) in placebo-controlled trials.
Morganroth J; Pratt CM; Kennedy HL; Singh SN; Platt ML; Baker BJ; Mason DT
Am J Cardiol; 1987 Oct; 60(11):48F-51F. PubMed ID: 3310585
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ethmozine to propranolol and the combination for ventricular arrhythmias.
Butman SM; Knoll ML; Gardin JM
Am J Cardiol; 1987 Sep; 60(7):603-7. PubMed ID: 2442994
[TBL] [Abstract][Full Text] [Related]
18. Effects of Ethmozine (moricizine HCl) on ventricular function using echocardiographic, hemodynamic and radionuclide assessments.
Pratt CM; Podrid PJ; Seals AA; Young JB; Hession M; Lampert S; Quiñones M; Lown B
Am J Cardiol; 1987 Oct; 60(11):73F-78F. PubMed ID: 3310589
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic drug testing in patients with malignant ventricular arrhythmias: importance of stimulation at more than one ventricular site.
Morady F; Hess D; Scheinman MM
Am J Cardiol; 1982 Nov; 50(5):1055-60. PubMed ID: 7137032
[TBL] [Abstract][Full Text] [Related]
20. A symposium: Pharmacological management of ventricular arrhythmias--current status in the role of moricizine HCl. October 19-22, 1989, Scottsdale, Arizona. Proceedings.
Am J Cardiol; 1990 Feb; 65(8):1D-71D. PubMed ID: 2407087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
